Himadri Speciality Chemical
Himadri Speciality Chemical
ChemicalsKey Fundamentals
SmallcapSpecialty ChemicalsChemicalsTapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Strengths
1- Company has delivered good profit growth of 73.7% CAGR over last 5 years
Weaknesses
1- Stock is trading at 7.13 times its book value
Growth Rate
AI Analysis — Bull vs Bear
Himadri Speciality Chemical Ltd commands a market cap of ₹34,185 Cr at a PE of 42.2x and PB of 7.21x. The company has delivered exceptional profit CAGR of 74% over 5 years and 47% over 3 years, while sales growth has been more modest at 4% CAGR over 3 years, indicating margin expansion rather than volume-led growth. The stock has appreciated 71% CAGR over 5 years, significantly outpacing its underlying sales growth.
- Exceptional profit growth of 73.7% CAGR over the last 5 years demonstrates strong operating leverage and improving margins
- TTM profit growth of 30% indicates continued earnings momentum even on a higher base
- ROE of 18% in the last year is an improvement over the 5-year average of 14% and 10-year average of 14%, showing rising capital efficiency
- 3-year ROE average of 17% is comfortably above cost of equity for most Indian chemical companies, indicating genuine value creation
- Long-term sales CAGR of 15% over 10 years reflects a structurally growing business with sustained revenue expansion
- 5-year sales CAGR of 23% shows the company accelerated its topline growth in the medium term relative to the 10-year trend
- 10-year profit CAGR of 44% significantly outpaces 10-year sales CAGR of 15%, pointing to sustained margin improvement and operating leverage over a long period
- Stock CAGR of 35% over 10 years indicates long-term wealth creation and sustained market confidence in the business trajectory
- PE of 42.2x is elevated for a specialty chemicals company, pricing in substantial future growth and leaving limited margin of safety
- PB of 7.21x is significantly above book value, meaning investors pay a steep premium relative to the company's net assets
- Sales growth has decelerated sharply to just 4% CAGR over 3 years and 10% TTM, compared to 23% over 5 years, raising questions about topline sustainability
- Dividend yield of just 0.12% offers negligible income return, indicating almost all returns depend on capital appreciation
- 1-year stock CAGR of 49% has run far ahead of TTM sales growth of 10% and TTM profit growth of 30%, suggesting valuation may have front-run fundamentals
- The widening gap between 3-year profit CAGR of 47% and 3-year sales CAGR of 4% suggests margin expansion may be near its limits, as margins cannot expand indefinitely without topline support
- Key financial ratios including debt-to-equity, ROCE, and EPS are unavailable, limiting the ability to fully assess balance sheet health and capital efficiency
- 52-week high and low data are unavailable, making it difficult to assess where the stock trades relative to its recent range
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
- Sicona battery tech investment done Aug 25
Himadri completed its final tranche of AUD 16.94 Mn in Sicona Battery Technologies via Compulsorily Convertible Notes on Aug 25, 2026, bringing total CCN investment to AUD 18.45 Mn.
TL;DR: Limited news flow for HSCL in this period. The company completed its strategic investment in Sicona Battery Technologies, signaling continued commitment to the battery materials space. No negative catalysts surfaced, but with only one neutral update, there is insufficient data to gauge near-term momentum. Watch for updates on Sicona's progress and any commercial milestones from HSCL's specialty chemicals or carbon materials segments.
Quarterly Results
| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 951 | 1,005 | 1,053 | 1,177 | 1,200 | 1,137 | 1,141 | 1,135 | 1,118 | 1,071 | 1,184 | 1,288 | 1,432 |
| Expenses | 817 | 847 | 879 | 997 | 1,008 | 929 | 920 | 901 | 873 | 838 | 941 | 1,046 | 1,144 |
| Operating Profit | 134 | 158 | 174 | 180 | 192 | 208 | 221 | 233 | 245 | 233 | 243 | 242 | 288 |
| OPM % | 14% | 16% | 17% | 15% | 16% | 18% | 19% | 21% | 22% | 22% | 20% | 19% | 20% |
| Other Income | 10 | 10 | 10 | 12 | 13 | 14 | 12 | 14 | 27 | 36 | 47 | 62 | 56 |
| Interest | 13 | 16 | 21 | 14 | 13 | 11 | 12 | 9 | 16 | 15 | 16 | 17 | 22 |
| Depreciation | 12 | 12 | 13 | 13 | 13 | 13 | 15 | 14 | 15 | 17 | 18 | 19 | 21 |
| PBT | 119 | 139 | 150 | 166 | 179 | 197 | 206 | 224 | 241 | 237 | 255 | 268 | 301 |
| Tax % | 28% | 28% | 28% | 30% | 31% | 31% | 31% | 31% | 26% | 26% | 25% | 23% | 24% |
| Net Profit | 86 | 101 | 109 | 115 | 123 | 136 | 141 | 155 | 179 | 176 | 192 | 208 | 228 |
| EPS in Rs | 1.96 | 2.29 | 2.47 | 2.34 | 2.48 | 2.74 | 2.88 | 3.15 | 3.68 | 3.57 | 3.81 | 3.98 | 4.55 |
Profit & Loss
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,437 | 1,182 | 1,341 | 2,022 | 2,422 | 1,806 | 1,679 | 2,791 | 4,172 | 4,185 | 4,613 | 4,661 | 4,974 |
| Expenses | 1,313 | 1,036 | 1,107 | 1,569 | 1,863 | 1,525 | 1,549 | 2,635 | 3,773 | 3,540 | 3,758 | 3,699 | 3,969 |
| Operating Profit | 124 | 146 | 233 | 452 | 560 | 280 | 131 | 156 | 399 | 645 | 854 | 962 | 1,005 |
| OPM % | 9% | 12% | 17% | 22% | 23% | 16% | 8% | 6% | 10% | 15% | 19% | 21% | 20% |
| Other Income | 13 | 9 | 6 | 12 | 8 | 8 | 14 | -17 | -2 | 43 | 52 | 171 | 201 |
| Interest | 103 | 111 | 82 | 70 | 71 | 55 | 33 | 36 | 66 | 64 | 45 | 64 | 71 |
| Depreciation | 59 | 67 | 33 | 33 | 34 | 39 | 47 | 50 | 51 | 50 | 55 | 68 | 75 |
| PBT | -24 | -23 | 125 | 361 | 462 | 194 | 65 | 53 | 280 | 574 | 806 | 1,001 | 1,060 |
| Tax % | -49% | -19% | 34% | 31% | 30% | -6% | 27% | 27% | 23% | 28% | 31% | 25% | — |
| Net Profit | -13 | -19 | 82 | 248 | 324 | 205 | 47 | 39 | 216 | 411 | 555 | 755 | 804 |
| EPS in Rs | -0.32 | -0.44 | 1.98 | 5.91 | 7.75 | 4.91 | 1.13 | 0.98 | 4.99 | 8.34 | 11.25 | 14.89 | 15.91 |
| Div. Payout % | 0% | -11% | 5% | 2% | 2% | 3% | 13% | 20% | 5% | 6% | 5% | 5% | — |
Balance Sheet
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 39 | 42 | 42 | 42 | 42 | 42 | 42 | 42 | 43 | 49 | 49 | 50 |
| Reserves | 750 | 837 | 988 | 1,373 | 1,590 | 1,692 | 1,751 | 1,826 | 2,237 | 2,996 | 3,672 | 4,656 |
| Borrowings | 1,124 | 887 | 774 | 660 | 476 | 505 | 729 | 587 | 842 | 605 | 313 | 770 |
| Other Liabilities | 329 | 296 | 308 | 341 | 680 | 323 | 269 | 999 | 555 | 798 | 621 | 830 |
| Total Liabilities | 2,242 | 2,062 | 2,112 | 2,416 | 2,788 | 2,562 | 2,791 | 3,454 | 3,678 | 4,449 | 4,656 | 6,306 |
| Fixed Assets | 1,228 | 1,180 | 1,174 | 1,178 | 1,170 | 1,475 | 1,468 | 1,546 | 1,515 | 1,534 | 1,605 | 1,942 |
| CWIP | 14 | 31 | 13 | 22 | 133 | 158 | 160 | 77 | 94 | 67 | 185 | 372 |
| Investments | 23 | 53 | 87 | 273 | 179 | 47 | 66 | 113 | 132 | 478 | 582 | 1,060 |
| Other Assets | 977 | 798 | 838 | 943 | 1,305 | 882 | 1,098 | 1,718 | 1,938 | 2,371 | 2,283 | 2,933 |
| Total Assets | 2,242 | 2,062 | 2,112 | 2,416 | 2,788 | 2,562 | 2,791 | 3,454 | 3,678 | 4,449 | 4,656 | 6,306 |
Cash Flow
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 212 | 296 | 205 | 258 | 476 | 283 | -40 | 331 | 54 | 405 | 447 | 382 |
| Investing | 128 | -6 | 10 | -50 | -224 | -214 | -114 | -28 | -397 | -405 | -235 | -963 |
| Financing | -348 | -278 | -233 | -200 | -257 | -41 | 165 | -182 | 377 | 7 | -271 | 590 |
| Net Cash Flow | -7 | 12 | -18 | 8 | -6 | 28 | 11 | 121 | 34 | 7 | -60 | 10 |
| Free Cash Flow | 184 | 281 | 201 | 195 | 272 | 36 | -76 | 308 | -22 | 352 | 276 | -63 |
| CFO/OP | 169 | 203 | 98 | 75 | 102 | 113 | -20 | 223 | 25 | 77 | 69 | 64 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 82 | 63 | 60 | 49 | 55 | 61 | 100 | 66 | 44 | 57 | 50 | 55 |
| Inventory Days | 122 | 138 | 164 | 112 | 124 | 121 | 100 | 125 | 61 | 85 | 68 | 96 |
| Days Payable | 36 | 50 | 74 | 39 | 100 | 68 | 45 | 127 | 39 | 69 | 28 | 47 |
| Cash Conversion Cycle | 168 | 151 | 150 | 122 | 79 | 113 | 155 | 65 | 66 | 73 | 90 | 103 |
| Working Capital Days | 4 | -22 | 19 | 29 | 40 | 10 | 15 | -1 | 1 | 32 | 69 | 57 |
| ROCE % | 3% | 5% | 11% | 22% | 25% | 11% | 4% | 5% | 13% | 19% | 22% | 22% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Himadri Speciality Chemical insights
64 extracted metrics + investor summaries across FY00–FY27.
Documents
Frequently Asked Questions about Himadri Speciality Chemical
What does Himadri Speciality Chemical Ltd do?
Where is Himadri Speciality Chemical Ltd (HSCL) listed?
Which sector does Himadri Speciality Chemical Ltd belong to?
What is the market capitalisation of Himadri Speciality Chemical Ltd?
What is the PE ratio of Himadri Speciality Chemical Ltd?
What is the 52-week high and low of Himadri Speciality Chemical Ltd?
Does Himadri Speciality Chemical Ltd pay dividends?
What is the Return on Equity (ROE) of Himadri Speciality Chemical Ltd?
Company Information
Himadri Speciality Chemical is primarily engaged in the manufacturing of carbon materials and chemicals.[1] It is the No.1 coal pitch manufacturer in India and is the only company to manufacture advanced carbon material in India. It is also the largest player of Naphthalene and SNF in India.[2]
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/HSCL.md for Himadri Speciality Chemical Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.